Change in Serum Biomarkers After Endovascular Treatment for Acute Anterior Circulation Large Vessel Occlusion - Trial NCT06383182
Access comprehensive clinical trial information for NCT06383182 through Pure Global AI's free database. This phase not specified trial is sponsored by General Hospital of Shenyang Military Region and is currently Not yet recruiting. The study focuses on Ischemic Stroke. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
General Hospital of Shenyang Military Region
Timeline & Enrollment
N/A
May 07, 2024
Dec 30, 2026
Primary Outcome
Dynamic changes in serum biomarkers after endovascular treatment
Summary
Acute ischaemic stroke (AIS) results in high rates of neurological morbidity and mortality,
 especially in patients with large vessel occlusion (LVO). Endovascular therapy (EVT) has been
 approved as the most effective treatment for patients with LVO , but about half patients
 undergoing EVT did not achieve good outcome. The mechanisms of poor prognosis are complex.
 How to accurately identify serological biomarkers related to patients' clinical prognosis is
 an important research topic nowadays.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06383182
Non-Device Trial